{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:28:24Z","timestamp":1792528104226,"version":"4.5.0"},"reference-count":85,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Many dermatological conditions, such as eczema and psoriasis, are treated with topical therapeutic products. Instead of applying the active drug directly onto the skin, it is combined with a vehicle to aid in its delivery across the stratum corneum (SC) and into deeper regions of the skin, namely the epidermis and dermis. Absorption into the systemic circulation is minimized. Topical vehicles are also used as cosmetic moisturizers (often termed emollient therapy) to ameliorate dry skin, which is a cornerstone of the management of various dermatological conditions, including xerosis, eczema, psoriasis, and aging. The most common topical vehicles include ointments, creams, gels, and lotions, among others. It is crucial that topical vehicles are chosen based upon the size and properties (wet\/dry, mucous\/non-mucous, healthy\/diseased) of the skin to be treated in order to optimize application and contact of the product with the skin, as this can have profound impacts on potency, efficacy, and patient compliance. This review examines common topical vehicles used for drug delivery and cosmetic moisturizers, including their formulation, advantages and disadvantages, and effects on the skin. The unique rules imposed by governing regulatory bodies in Australia and around the world, in terms of topical product claims, are also briefly examined.<\/jats:p>","DOI":"10.3390\/pharmaceutics13122012","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:22:56Z","timestamp":1638314576000},"page":"2012","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison"],"prefix":"10.3390","volume":"13","author":[{"given":"Tanya M.","family":"Barnes","sequence":"first","affiliation":[{"name":"Department of Scientific Affairs, Ego Pharmaceuticals Pty Ltd., Braeside, VIC 3195, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8519-286X","authenticated-orcid":false,"given":"Dalibor","family":"Mijaljica","sequence":"additional","affiliation":[{"name":"Department of Scientific Affairs, Ego Pharmaceuticals Pty Ltd., Braeside, VIC 3195, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua P.","family":"Townley","sequence":"additional","affiliation":[{"name":"Department of Scientific Affairs, Ego Pharmaceuticals Pty Ltd., Braeside, VIC 3195, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-6301","authenticated-orcid":false,"given":"Fabrizio","family":"Spada","sequence":"additional","affiliation":[{"name":"Department of Scientific Affairs, Ego Pharmaceuticals Pty Ltd., Braeside, VIC 3195, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5269-5823","authenticated-orcid":false,"given":"Ian P.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Scientific Affairs, Ego Pharmaceuticals Pty Ltd., Braeside, VIC 3195, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.0022-202X.2005.23668.x","article-title":"Stratum corneum defensive functions: An integrated view","volume":"125","author":"Elias","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.36849\/JDD.589a","article-title":"Evolution of skin barrier science for healthy and compromised skin","volume":"20","author":"Haftek","year":"2021","journal-title":"J. Drugs. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"864734","DOI":"10.1155\/2012\/864734","article-title":"Methods to assess the protective efficacy of emollients against climatic and chemical aggressors","volume":"2012","author":"Roure","year":"2012","journal-title":"Dermatol. Res. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12272-021-01305-x","article-title":"Skin barrier dysfunction and filaggrin","volume":"44","author":"Kim","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/jocd.14217","article-title":"A new era of moisturizers","volume":"20","author":"Chandan","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","article-title":"Pathophysiology of atopic dermatitis: Clinical implications","volume":"40","author":"Kim","year":"2019","journal-title":"Allergy Asthma Proc."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Harrison, I.P., and Spada, F. (2019). Breaking the itch-scratch cycle: Topical options for the management of chronic cutaneous itch in atopic dermatitis. Medicines, 6.","DOI":"10.3390\/medicines6030076"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s43440-020-00206-y","article-title":"Pruritus in psoriasis and atopic dermatitis: Current treatments and new perspectives","volume":"73","author":"Kahremany","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2133.2002.04852.x","article-title":"Dermatitis caused by physical irritants","volume":"147","author":"Robertson","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0926-9959(96)00030-X","article-title":"The role of Staphylococcus aureus in atopic eczema: Treatment strategies","volume":"7","author":"Cork","year":"1996","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_11","first-page":"76","article-title":"Cleansers and moisturisers: The basics","volume":"23","author":"Greive","year":"2015","journal-title":"Wound. Pract. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.18632\/aging.102946","article-title":"Aging-associated alterations in epidermal function and their clinical significance","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dragi\u0107evi\u0107, N., and Maibach, H. (2021). Vehicles and Topical Therapy. Chapter 47. Percutaneous Absorption. Drugs, Cosmetics, Mechanisms, Methods, CRC Press. [5th ed.].","DOI":"10.1201\/9780429202971"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","article-title":"Novel mechanisms and devices to enable successful transdermal drug delivery","volume":"14","author":"Barry","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_15","first-page":"e50638","article-title":"Models and methods to evaluate transport of drug delivery systems across cellular barriers","volume":"80","author":"Ghaffarian","year":"2013","journal-title":"J. Vis. Exp."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Marks, R., and Plewig, G. (1983). The Intercomeocyte Space. Stratum Corneum, Springer. [1st ed.].","DOI":"10.1007\/978-3-642-68682-5"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejpb.2004.03.002","article-title":"Skin deep","volume":"58","author":"Hadgraft","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1073\/pnas.87.10.3871","article-title":"Lipid biophysics of water loss through the skin","volume":"87","author":"Potts","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dragicevic, N., and Maibach, H. (2015). Skin Deep: The basics of Human Skin Structure and Drug Penetration. Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, Springer. [1st ed.].","DOI":"10.1007\/978-3-662-45013-0"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.0022-202X.2003.22110.x","article-title":"Variations of hair follicle size and distribution in different body sites","volume":"122","author":"Otberg","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/1874126600701010036","article-title":"Innovative strategies for enhancing topical and transdermal drug delivery","volume":"1","author":"Morrow","year":"2007","journal-title":"Open Drug. Deliv. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1567201052772915","article-title":"Transdermal drug delivery: Penetration enhancement techniques","volume":"2","author":"Benson","year":"2005","journal-title":"Curr. Drug. Deliv."},{"key":"ref_23","unstructured":"Kircik, L., Bikowski, J., Cohen, D.E., Draelos, Z.D., Hebert, A., and West, D.P. (2010). Formulation development, testing, and approval: Part 1of 2. Pract. Dermatol., 1\u201316."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Benson, H.A.E., and Watkinson, A. (2012). Topical Product Formulation Development. Transdermal and Topical Drug Delivery: Principles and Practice, John Wiley and Sons. [1st ed.].","DOI":"10.1002\/9781118140505.ch18"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Danby, S.G., Draelos, Z.D., Stein Gold, L.F., Cha, A., Vlahos, B., Aikman, L., Sanders, P., Wu-Linhares, D., and Cork, M.J. (2020). Vehicles for atopic dermatitis therapies: More than just a placebo. J. Dermatolog. Treat., 1\u201314.","DOI":"10.1080\/09546634.2020.1789050"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1203475417743234","article-title":"A Guide to topical vehicle formulations","volume":"22","author":"Mayba","year":"2018","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_27","first-page":"1431","article-title":"Principles and approaches for optimizing therapy with unique topical vehicles","volume":"13","author":"Rosen","year":"2014","journal-title":"J. Drugs. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2005.01.032","article-title":"Topical drug classification","volume":"295","author":"Buhse","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_29","unstructured":"Goldsmith, L.A., Katz, S.I., Gilchrest, B.A., Paller, A.S., Leffell, D.J., and Wolff, K. (2012). Principles of Topical Therapy. Chapter 214. Fitzpatrick\u2019s Dermatology in General Medicine, McGraw-Hill. [8th ed.]."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0738-081X(97)00020-5","article-title":"Corticosteroids","volume":"15","author":"Hughes","year":"1997","journal-title":"Clin. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1517\/17425247.2012.711756","article-title":"Topical drug delivery systems in dermatology: A review of patient adherence issues","volume":"9","author":"Tan","year":"2012","journal-title":"Expert Opin. Drug. Deliv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaad.2005.04.030","article-title":"Corticosteroids: Options in the era of steroid-sparing therapy","volume":"53","author":"Friedlander","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1529-8019.2012.01458.x","article-title":"Conventional topical delivery systems","volume":"24","author":"Weiss","year":"2011","journal-title":"Dermatol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaad.2005.04.028","article-title":"A novel foam vehicle for delivery of topical corticosteroids","volume":"53","author":"Huang","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0738-081X(89)90003-5","article-title":"Dermatologic vehicles","volume":"7","author":"Sibbald","year":"1989","journal-title":"Clin. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1468-3083.2011.04113.x","article-title":"Factors impacting the combination of topical corticosteroid therapies for psoriasis: Perspectives from the International Psoriasis Council","volume":"25","author":"Kragballe","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_37","first-page":"870","article-title":"Differences in cutaneous irritation of five commonly used topical products","volume":"15","author":"Draelos","year":"2016","journal-title":"J. Drugs. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000082572","article-title":"The mystical effects of dermatological vehicles","volume":"210","author":"Surber","year":"2005","journal-title":"Dermatology"},{"key":"ref_39","first-page":"1","article-title":"Principles of Topical Therapy. Chapter 18","volume":"Volume 4","author":"Griffiths","year":"2016","journal-title":"Rook\u2019s Textbook of Dermatology"},{"key":"ref_40","first-page":"15","article-title":"Relationship between skin permeability and cornecyte size according to anatomic site, age and sex in man","volume":"39","author":"Rougier","year":"1988","journal-title":"J. Soc. Cosmet. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, A., P\u00e9ter-H\u00e9deri, D., Perei, K., Budai-Szucs, M., L\u00e9ber, A., G\u00e1csi, A., Cs\u00e1nyi, E., and Berk\u00f3, S. (2020). Effects of formulation excipients on skin barrier function in creams used in pediatric care. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080729"},{"key":"ref_42","first-page":"5","article-title":"The evolution of topical formulations in psoriasis","volume":"23","author":"Kuehl","year":"2018","journal-title":"Skin. Ther. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jdv.12442","article-title":"Treatment adherence: A hurdle for real-life effectiveness in psoriasis?","volume":"28","author":"Reich","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jdv.12443","article-title":"Expert recommendations: The use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis","volume":"28","author":"Bewley","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaad.2005.12.021","article-title":"Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis","volume":"55","author":"Brown","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04060.x","article-title":"Maximizing patient adherence for optimal outcomes in psoriasis","volume":"25","author":"Bewley","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_47","first-page":"337","article-title":"Topical corticosteroids: Choice and application","volume":"103","author":"Stacey","year":"2021","journal-title":"Am. Fam. Physician."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7861\/clinmedicine.16-1-66","article-title":"Atopic eczema","volume":"16","author":"Brown","year":"2016","journal-title":"Clin. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3121\/cmr.2017.1363","article-title":"The role of moisturizers in addressing various kinds of dermatitis: A Review","volume":"15","author":"Purnamawati","year":"2017","journal-title":"Clin. Med. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/000155502320624023","article-title":"Hydration and plasticity following long-term use of a moisturizer: A single-blind study","volume":"82","author":"Jemec","year":"2002","journal-title":"Acta Derm. Venereol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2165\/00128071-200304110-00005","article-title":"Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders","volume":"4","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0733-8635(05)70210-2","article-title":"Therapeutic moisturizers","volume":"18","author":"Draelos","year":"2000","journal-title":"Dermatol. Clin."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clindermatol.2011.08.015","article-title":"Effect of moisturizers on epidermal barrier function","volume":"30","year":"2012","journal-title":"Clin. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1529-8019.2012.01504.x","article-title":"Moisturizers: Reality and the skin benefits","volume":"25","author":"Nolan","year":"2012","journal-title":"Dermatol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/0019-5154.182427","article-title":"Moisturizers: The slippery road","volume":"61","author":"Sethi","year":"2016","journal-title":"Indian J. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1396-0296.2004.04S1006.x","article-title":"Moisturizer technology versus clinical performance","volume":"17","author":"Rawlings","year":"2004","journal-title":"Dermatol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/CCID.S177697","article-title":"Skin hydration is significantly increased by a cream formulated to mimic the skin\u2019s own natural moisturizing systems","volume":"11","author":"Spada","year":"2018","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1600-0625.2009.00881.x","article-title":"Hydrophilic and lipophilic moisturisers have similar penetration profiles but different effects on SC water distribution in vivo","volume":"18","author":"Caussin","year":"2009","journal-title":"Exp. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1208\/s12248-012-9411-0","article-title":"Generic development of topical dermatologic products: Formulation development, process development, and testing of topical dermatologic products","volume":"15","author":"Chang","year":"2013","journal-title":"AAPS J."},{"key":"ref_60","first-page":"1","article-title":"Moisturizers: What they are and a practical approach to product selection","volume":"10","author":"Kraft","year":"2005","journal-title":"Skin Ther. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1468-3083.2005.01326.x","article-title":"The clinical benefit of moisturizers","volume":"19","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_62","unstructured":"Downie, J.B. (2010). Understanding moisturizers and their clinical benefits. Pract. Dermatol. Pediatr., 19\u201322."},{"key":"ref_63","first-page":"31","article-title":"A guide to the ingredients and potential benefits of over-the-counter cleansers and moisturizers for rosacea patients","volume":"4","author":"Levin","year":"2011","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1467-2494.1999.236815.x","article-title":"Skin moisturisation and elasticity originate from at least two different mechanisms","volume":"21","author":"Wiechers","year":"1999","journal-title":"Int. J. Cosmet. Sci."},{"key":"ref_65","first-page":"3","article-title":"Moisturizers: What they are and how they work","volume":"6","author":"Lynde","year":"2001","journal-title":"Skin Ther. Lett."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e14970","DOI":"10.1111\/dth.14970","article-title":"A daily regimen of a ceramide-dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial","volume":"34","author":"Spada","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_67","first-page":"26","article-title":"Multivesicular emulsion ceramide-containing moisturizers: An evaluation of their role in the management of common skin disorders","volume":"9","author":"Zeichner","year":"2016","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ad.2016.05.015","article-title":"Nicotinamide: New indications in dermatology","volume":"107","year":"2016","journal-title":"Actas Dermosifiliogr."},{"key":"ref_69","first-page":"14","article-title":"Topical vitamin C and the skin: Mechanisms of action and clinical applications","volume":"10","author":"Chiang","year":"2017","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6015351","DOI":"10.1155\/2018\/6015351","article-title":"Biological activities, health benefits, and therapeutic properties of avenanthramides: From skin protection to prevention and treatment of cerebrovascular diseases","volume":"2018","author":"Perrelli","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40257-013-0033-9","article-title":"Barrier repair therapy in atopic dermatitis: An overview","volume":"14","author":"Hon","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_72","first-page":"3","article-title":"The use of therapeutic moisturizers in various dermatologic disorders","volume":"68","author":"Bikowski","year":"2001","journal-title":"Cutis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/jocd.12490","article-title":"The science behind skin care: Moisturizers","volume":"17","author":"Draelos","year":"2018","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_74","unstructured":"Frost, P., and Horwitz, S.N. (1982). Moisturizers, Emollients, And Bath Oils. Principles of Cosmetics for the Dermatologist, Mosby Company. [1st ed.]."},{"key":"ref_75","unstructured":"Williams, D.F., and Schmitt, W.H. (1992). Skin-Care Products. Chemistry and Technology of the Cosmetics and Toiletries Industry, Blackie Academic & Professional. [2nd ed.]."},{"key":"ref_76","unstructured":"Thompson, J.E. (2009). Surfactants and Emulsifying Agents. Chapter 20. A Practical Guide to Contemporary Pharmacy Practice, Lippincott Williams & Wilkins. [3rd ed.]."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0168-3659(01)00290-5","article-title":"Enhanced skin permeation of a lipophilic drug using supersaturated formulations","volume":"73","author":"Moser","year":"2001","journal-title":"J. Control. Release"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.15171\/apb.2018.021","article-title":"Chemical enhancer: A simplistic way to modulate barrier function of the stratum corneum","volume":"8","author":"Haque","year":"2018","journal-title":"Adv. Pharm. Bull."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2012.09.032","article-title":"Penetration enhancers","volume":"64","author":"Williams","year":"2012","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.0105-1873.2005.00693.x","article-title":"Skin-sensitizing and irritant properties of propylene glycol","volume":"53","author":"Lessmann","year":"2005","journal-title":"Contact Dermat."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1358\/mf.2003.25.6.769645","article-title":"Transdermal drug delivery of tricyclic antidepressants: Effect of fatty acids","volume":"25","author":"Jain","year":"2003","journal-title":"Methods. Find. Exp. Clin. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1600-0625.2006.00478.x","article-title":"Increased permeability for polyethylene glycols through skin compromised by sodium lauryl sulphate","volume":"15","author":"Jakasa","year":"2006","journal-title":"Exp. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.21276\/ijprhs.2016.05.01","article-title":"Regulatory requirements for cosmetics in relation with regulatory authorities in India against US, Europe, Australia and Asean countries","volume":"4","author":"Raj","year":"2016","journal-title":"Int. J. Pharm. Res. Health. Sci."},{"key":"ref_84","first-page":"22","article-title":"Cosmetic moisturizers, topical drug vehicles","volume":"42","author":"Draelos","year":"2021","journal-title":"Dermatol. Times"},{"key":"ref_85","unstructured":"(2021, October 13). Qualification of Excipients for Use in Pharmaceuticals. Available online: https:\/\/ipecamericas.org."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/12\/2012\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:36:08Z","timestamp":1760168168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/12\/2012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":85,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["pharmaceutics13122012"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13122012","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}